Location History:
- Leimen, DE (1995 - 1997)
- Nussloch, DE (1998)
Company Filing History:
2 out of 5 
1 out of 2 
1 out of 832,761 Years Active: 1995-1998
Title: Franz Herbst: Innovator in Peptide Research
Introduction
Franz Herbst is a notable inventor based in Leimen, Germany. He has made significant contributions to the field of peptide research, holding a total of 3 patents. His work focuses on the diagnostic and therapeutic applications of peptides derived from human blood.
Latest Patents
Herbst's latest patents include the development of the hPTH-(1-37) peptide fragment. This invention relates to a peptide from human blood, which has been elucidated for diagnostic, medical, and commercial utilization. The isolation of the hPTH-(38-84) fragment confirms the existence of hPTH-(1-37). It has been found that the removal of amino-terminal amino acids from the hPTH fragment-(1-37) reduces its biological activity. The circulating hPTH-(1-37) in the blood is identical to the synthetic reference substance, but differs from other fragments such as hPTH-(1-33), hPTH-(1-34), or hPTH-(1-38). Mass spectrometry has proven the molecular form of hPTH-(1-37). The unique biological activity and three-dimensional structure of this fragment suggest its potential use in treating diseases related to the parathyroid, circulatory system, respiratory system, male genital organs, and kidneys. Another significant patent involves the cardiodilatin fragment, which comprises the amino acid sequence 95-126 of ANF/CDD 1-126. This peptide fragment is formed in the kidney and has various medical indications.
Career Highlights
Throughout his career, Franz Herbst has worked with several companies, including Haemopep Pharma GmbH and Pharma Bissendorf Peptide GmbH. His innovative research has contributed to advancements in peptide-based therapeutics.
Collaborations
Some of his notable collaborators include Wolf-Georg Forssmann and Jeanette M Alt. Their combined expertise has furthered the understanding and application of peptide research.
Conclusion
Franz Herbst's contributions to peptide research and his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments and diagnostics.